ImmVira Group ("ImmVira") today announced that updated clinical data from three bladder cancer studies of its lead oncolytic ...
Moderna released full data on its closely watched cancer vaccine developed with Merck.
A combination of the personalized cancer vaccine intismeran autogene and Merck's Keytruda just barely cleared analysts’ ...
Flow Space on MSN
6 breast cancer innovations changing the face of disease
From AI risk assessment to tests that help you choose the best course of treatment, breast cancer innovations are moving us ...
A combination of the shot and the immunotherapy Keytruda cut the risk of relapse or death by 42% in a landmark melanoma study ...
DataM Intelligence’s report analyzes therapy, stage, end-user and regional segments, including pipeline developments, company ...
Dublin, Oct. 22, 2026 (GLOBE NEWSWIRE) -- "Metastatic HR+/HER2- Breast Cancer - Market Insights, Epidemiology, and Market Forecast - 2036" has been added to ResearchAndMarkets.com's offering. The ...
Brain cancer remains one of the hardest cancers to treat, and researchers are under pressure to find therapies that do more than slow the disease for a short time. For patients with aggressive tumors ...
REDWOOD CITY, Calif., Oct. 20, 2026 (GLOBE NEWSWIRE) -- (Nasdaq: RVMD), a global, commercial-stage oncology company dedicated to discovering, developing and delivering innovative medicines for ...
The leaked Phase 3 data is clinically meaningful: hazard ratio 0.58 for recurrence/death and 82% recurrence-free survival at ...
The decline in oncological care in Cuba is revealed in an official report that acknowledges the absence of thousands of ...
Insurance coverage requirements and high out-of-pocket costs often delay or limit patients’ access to specialty oral blood cancer drugs, according to study results.An analysis of nationwide claims dat ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results